Molecular Templates (MTEM) Earnings Date, Estimates & Call Transcripts → What is the 72-Hour Profit Surge? (From DTI) (Ad) Free MTEM Stock Alerts $1.58 -0.06 (-3.66%) (As of 03:05 PM ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 20EstimatedActual EPS (Mar. 29) -$0.73 Beat By $1.37 Consensus EPS (Mar. 29) -$2.10 Get Molecular Templates Earnings AlertsEnter your email address below to receive the latest news and earnings results for MTEM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMTEM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MTEM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << Molecular Templates Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.70) EPSNext Year EPS Consensus Estimate: ($2.85) EPSMTEM Earnings Date and InformationMolecular Templates last announced its earnings results on March 29th, 2024. The biotechnology company reported ($0.73) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.10) by $1.37. The company earned $7.02 million during the quarter. Molecular Templates has generated ($1.55) earnings per share over the last year (($1.55) diluted earnings per share). Earnings for Molecular Templates are expected to decrease in the coming year, from ($2.70) to ($2.85) per share. Molecular Templates has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.Read More Molecular Templates Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Estimated)------- 3/29/2024Q4 2023($2.10)($0.73)+$1.37($0.73)-$7.02 million11/13/2023Q3 2023($2.70)($0.82)+$1.88($0.82)-$6.80 million8/10/2023Q2 2023($5.25)($3.30)+$1.95($3.75)-$6.87 million5/15/2023Q1 2023($4.65)$2.85+$7.50$0.19-$36.63 million3/30/2023Q4 2022($3.75)($5.85)($2.10)($0.39)$7.25 million$2.61 million11/10/2022Q3 2022($7.20)($6.60)+$0.60($0.44)$4.00 million$4.24 million Get the Latest News and Ratings for MTEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($6.45)($6.60)($0.15)($0.44)$6.38 million$4.42 million5/12/2022Q1 2022($6.30)($5.70)+$0.60($0.38)$6.88 million$8.49 million 3/28/2022Q4 2021($2.70)($2.70)-($0.18)$21.95 million$17.96 million11/15/2021Q3($5.67)($8.10)($2.43)($0.54)$15.69 million$2.38 million8/12/2021Q2 2021($4.50)($4.20)+$0.30($0.28)$30.67 million$15.13 million5/13/2021Q1 2021$4.65($7.65)($12.30)($0.51)$29.66 million$3.22 million Molecular Templates Earnings - Frequently Asked Questions When is Molecular Templates's earnings date? Molecular Templates has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on MTEM's earnings history. Did Molecular Templates beat their earnings estimates last quarter? In the previous quarter, Molecular Templates (NASDAQ:MTEM) reported ($0.73) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.10) by $1.37. Learn more on analysts' earnings estimate vs. MTEM's actual earnings. How much revenue does Molecular Templates generate each year? Molecular Templates (NASDAQ:MTEM) has a recorded annual revenue of $57.31 million. How much profit does Molecular Templates generate each year? Molecular Templates (NASDAQ:MTEM) has a recorded net income of -$8.12 million. MTEM has generated -$1.55 earnings per share over the last four quarters. What is Molecular Templates's EPS forecast for next year? Molecular Templates's earnings are expected to decrease from ($2.70) per share to ($2.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Fortress Biotech Earnings Results Longeveron Earnings Results Hepion Pharmaceuticals Earnings Results Adial Pharmaceuticals Earnings Results Virios Therapeutics Earnings Results Biofrontera Earnings Results Galera Therapeutics Earnings Results Cyclerion Therapeutics Earnings Results TFF Pharmaceuticals Earnings Results Aeterna Zentaris Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:MTEM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Templates, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
